Biological function of testican-2 in podocyte health
testican-2 在足细胞健康中的生物学功能
基本信息
- 批准号:10867983
- 负责人:
- 金额:$ 7.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:ActinsAdhesionsAdriamycin PFSAdvisory CommitteesAffinityAlbuminuriaAortaAreaAttenuatedBindingBiological MarkersBiological ProcessBiologyBloodBostonCell surfaceCellsChronic Kidney FailureCirculationClinical ResearchCreatinineCytoskeletonDataDedicationsDiabetic NephropathyEmerging TechnologiesEnzyme-Linked Immunosorbent AssayEtiologyExtracellular MatrixExtracellular Matrix ProteinsFellowshipFocal and Segmental GlomerulosclerosisFutureGeneral PopulationGenesGeneticGlomerular Filtration RateGlycoproteinsGoalsGrantHealthHumanITGB3 geneImmunoassayImmunofluorescence ImmunologicIn VitroIndividualInjuryIntegrin alphaVbeta3InterferometryInterstitial NephritisKidneyKidney DiseasesKnowledgeLigandsManuscriptsMass Spectrum AnalysisMeasuresMediatingMentorsMentorshipMicroscopyMusNephrologyPatientsPeptidesPhysiciansPhysiologyPlayPrognosisProteinsProteomicsPublic SpeakingPublicationsRGD (sequence)Renal glomerular diseaseResearchResearch PersonnelResearch TrainingRoleSamplingScienceScientistSerumSignal TransductionSite-Directed MutagenesisStructureStructure of renal veinSurfaceTertiary Protein StructureTestingTherapeuticTimeTissue SampleTissuesTrainingVitronectinWritingaptamercareercareer developmentcohortexperienceglomerulosclerosishuman subjectin vivoinhibitorinsightkidney biopsykidney metabolismknock-downmultidisciplinarynovelnovel therapeutic interventionoverexpressionpodocytepopulation basedprognosticprotective effectprotein protein interactionsingle-cell RNA sequencingtherapeutic targettissue biomarkerstraining opportunitytranslational approach
项目摘要
PROJECT SUMMARY/ABSTRACT
Using a proteomic screen of samples obtained from the aorta and renal vein of human subjects, we
recently identified testican-2 as a podocyte-derived protein that is released by the kidney into circulation. Further,
we found that testican-2 levels are positively correlated with estimated glomerular filtration rate (eGFR) and
higher baseline levels of testican-2 are associated with less eGFR loss over time, advancing the concept that
testican-2 provides insight on kidney health and prognosis. However, the biological function of testican-2 in
podocytes and the kidney is unknown. Encoded by the SPOCK2 gene, testican-2 is a glycoprotein that is a
component of the extracellular matrix (ECM). In preliminary data generated by the PI, we find that testican-2
attenuates podocyte injury induced by Adriamcyin both in cultured human podocytes and mice. We further find
that testican-2 binds to another ECM protein vitronectin and reduces its binding affinity to integrin αVβ3, an
adhesion protein on the podocyte surface. Using these findings as a springboard, this proposal will test the
central hypothesis that testican-2 plays a functional role in podocyte health by reducing vitronectin-mediated
integrin αVβ3 activation and signaling: Aim 1) To determine the protein domain required for testican-2 binding
with vitronectin; Aim 2) To determine the impact of testican-2 on integrin αVβ3 activation and podocyte injury;
and Aim 3) To assess testican-2 expression in patients with diabetic nephropathy and primary focal segmental
glomerulosclerosis. The candidate, Dr. Wen, is deeply committed to a career in academic nephrology. He
previously pursued broad-based research training in nephrology, with a particular focus on renal physiology.
Since pursuing a nephrology fellowship in 2018, he has shifted his focus to a new area—the biological function
of testican-2 in podocyte health, with both basic and translational approaches. Dr. Wen’s immediate career goals
include acquiring content knowledge and hands-on experience with emerging technologies in the areas of
podocyte biology; protein-protein interaction and structure; and blood and tissue biomarkers. In addition, he
seeks training with public speaking and grant and manuscript writing. Dr. Wen’s long-term career goal is to
become an independent physician-scientist who pursues both basic and translational approaches to develop
new therapeutic strategies for patients with podocytes injury, and kidney disease in general. He will benefit from
complementary mentorship from Eugene Rhee (mentor; Chief, MGH Nephrology), an expert in kidney
metabolism and biomarkers; and Martin Pollak (co-mentor, Chief, BIDMC Nephrology), a leader in genetics and
podocyte biology. Drs. Wen, Rhee, and Pollak will meet frequently to discuss both science and career
development and have clearly identified aspects of the research proposed that will form the basis of his
independent career. An advisory committee will provide additional guidance, evaluate progress, and help plan
future directions.
项目总结/摘要
使用从人类受试者的主动脉和肾静脉获得的样品的蛋白质组学筛选,
最近鉴定出testican-2是一种足细胞衍生的蛋白质,由肾脏释放到循环中。此外,本发明还
我们发现睾丸素-2水平与估计的肾小球滤过率(eGFR)呈正相关,
睾丸素-2的基线水平越高,随着时间的推移eGFR损失越少,这一概念进一步发展,
testican-2提供了对肾脏健康和预后的见解。然而,睾丸素-2的生物学功能,
足细胞和肾脏尚不清楚。由SPOCK 2基因编码,睾丸素-2是一种糖蛋白,
细胞外基质(ECM)的组成部分。在PI生成的初步数据中,我们发现testican-2
在培养的人足细胞和小鼠中减弱阿霉素诱导的足细胞损伤。我们进一步发现,
睾丸素-2与另一种ECM蛋白玻连蛋白结合,并降低其与整合素αVβ3的结合亲和力,
足细胞表面的粘附蛋白。以这些发现为出发点,本提案将测试
中心假设睾丸素-2通过减少玻连蛋白介导的
整合素αVβ3的激活和信号传导:目的1)确定睾丸素2结合所需的蛋白结构域
目的2)确定睾丸素-2对整合素αVβ3激活和足细胞损伤的影响;
目的3)探讨睾丸素-2(testican-2)在糖尿病肾病(DN)患者肾组织中的表达及意义
肾小球硬化候选人温博士致力于学术肾病学的事业。他
以前在肾脏学方面进行了广泛的研究培训,特别关注肾脏生理学。
自2018年获得肾脏病学奖学金以来,他已将重点转移到一个新的领域-生物功能
testican-2在足细胞健康中的作用,包括基本方法和翻译方法。温博士的近期职业目标
包括获取内容知识和实践经验,与新兴技术领域,
足细胞生物学;蛋白质-蛋白质相互作用和结构;以及血液和组织生物标志物。此外他
寻求公开演讲、赠款和手稿写作方面的培训。温博士的长期职业目标是
成为一个独立的物理学家,科学家谁追求的基本和转化的方法来发展
足细胞损伤和一般肾脏疾病患者的新治疗策略。他将受益于
来自肾脏专家尤金·李(导师; MGH肾脏科主任)的补充指导
和Martin Pollak(共同导师,主任,BIDMC肾病),遗传学和生物标志物领域的领导者,
足细胞生物学文博士、李承晚博士和波拉克博士将经常会面,讨论科学和职业问题
发展,并已明确确定的研究方面提出,将形成他的基础,
独立的职业生涯。咨询委员会将提供额外指导、评估进展并帮助计划
未来的方向
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donghai Wen其他文献
Donghai Wen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donghai Wen', 18)}}的其他基金
Biological function of testican-2 in podocyte health
testican-2 在足细胞健康中的生物学功能
- 批准号:
10426944 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Biological function of testican-2 in podocyte health
testican-2 在足细胞健康中的生物学功能
- 批准号:
10599209 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 7.56万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 7.56万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 7.56万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别: